PLATFORM: PLATelet Function Operating Room Monitoring

Sponsor
IRCCS Policlinico S. Donato (Other)
Overall Status
Completed
CT.gov ID
NCT03121898
Collaborator
(none)
490
1
13.9
35.3

Study Details

Study Description

Brief Summary

Prospective cohort study on adult cardiac surgery patients. Platelet function evaluated before and after cardiopulmonary bypass. Bleeding and transfusion recorded. Primary endpoint is finding the association between postoperative platelet function and bleeding.

Condition or Disease Intervention/Treatment Phase
  • Device: Platelet function test

Detailed Description

Preoperative platelet function is a known determinant of postoperative bleeding in cardiac surgery patients (1,2). Conversely, there is a lack of information with respect to postoperative platelet function and postoperative bleeding, and specific cut-off values have not been identified yet.

This study will verify the hypothesis that postoperative platelet function is associated with bleeding, and will test the ability of platelet function tests (PFTs) in predicting severe postoperative bleeding. Additional analyses linking platelet function to other preoperative and intraoperative conditions are planned.

Patients: Enrollment between February 2017 and January 2018. 800 consecutive adult cardiac surgery patients are considered based on our usual surgical activity. Exclusion criteria: unwillingness to participate, known congenital coagulopathy. Moderate/severe bleeding occurs in about 12% of our patient population. Considering a 15% dropout rate, there are about 80 predicted events. Power analysis: to build a predictive model, at least 60 events of moderate/severe bleeding are required. The study will be stopped at reaching (whatever comes first) 800 enrolled pts; 60 events; or 31st January 2018.

Methods: all the patients will receive a preoperative (in the operating room) PFT (ADPtest and TRAPtest) using the aggregometry Multiplate (Roche). The same test will be repeated after protamine administration at the end of CPB.

Definitions of bleeding: 12-hours chest drain blood loss; moderate/severe bleeding adjudicated based on the universal definition of perioperative bleeding (3).

Statistics: ROC analysis with identification of adequate cut-off values and definition of the PPV and NPV

Study Design

Study Type:
Observational
Actual Enrollment :
490 participants
Observational Model:
Cohort
Time Perspective:
Prospective
Official Title:
PLATelet Function Operating Room Monitoring
Actual Study Start Date :
Feb 1, 2017
Actual Primary Completion Date :
Jan 31, 2018
Actual Study Completion Date :
Mar 31, 2018

Outcome Measures

Primary Outcome Measures

  1. Postoperative bleeding [12 hours]

    Chest drain blood loss

Secondary Outcome Measures

  1. Transfusions [24 hours]

    RBC, FFP, and Platelet concentrate transfusions

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 95 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Cardiac surgery with CPB
Exclusion Criteria:
  • Known congenital coagulopathy

Contacts and Locations

Locations

Site City State Country Postal Code
1 IRCCS Policlinico San Donato San Donato Milanese Milan Italy 20097

Sponsors and Collaborators

  • IRCCS Policlinico S. Donato

Investigators

  • Principal Investigator: Marco Ranucci, MD, IRCCS Policlinico San Donato

Study Documents (Full-Text)

None provided.

More Information

Publications

Responsible Party:
Marco Ranucci, Head of Cardiothoracic Anesthesia and ICU depy, IRCCS Policlinico S. Donato
ClinicalTrials.gov Identifier:
NCT03121898
Other Study ID Numbers:
  • PlateletMonitoring
First Posted:
Apr 20, 2017
Last Update Posted:
Jun 22, 2020
Last Verified:
Jun 1, 2020
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No

Study Results

No Results Posted as of Jun 22, 2020